FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

Go back to FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
(NASDAQ: FBRX) Delayed: 59.70 +3.07 (5.42%)
Previous Close $56.63    52 Week High
Open $55.36    52 Week Low
Day High $62.46    P/E N/A 
Day Low $54.26    EPS
Volume 752,137